Sign In
Buy KOD
$33.87
+0.655 (+1.97%)
At Close: Jun 03, 2026
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $28.29 Consensus Target Price from Brokerages
02:52am, Thursday, 05'th Mar 2026
Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) has received an average recommendation of "Moderate Buy" from the eight analysts that are currently covering the company, Marketbeat.com reports. O
Kodiak Sciences Stock Up 480% as One Fund Discloses $53 Million Buy
01:20pm, Monday, 23'rd Feb 2026
Baker Bros. Advisors increased its Kodiak Sciences stake by 2,608,696 shares; the estimated trade size was $53.42 million.
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.9% – What’s Next?
04:36am, Sunday, 22'nd Feb 2026
Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report)'s stock price dropped 5.9% on Friday. The stock traded as low as $25.32 and last traded at $25.1010. Approximately 60,109 shares changed hands duri
Inside a $58 Million Bet on Kodiak Amid $184 Million Offering and Phase 3 Readouts Ahead
05:14pm, Thursday, 19'th Feb 2026
Connecticut-based Braidwell bought 2,072,788 shares in Kodiak Sciences in the fourth quarter. The quarter-end position value increased by $57.96 million, reflecting the establishment of the new positi
Abbott Laboratories: A Key Reduction in Robert Bruce's Portfolio
06:01pm, Friday, 13'th Feb 2026
Exploring the Strategic Moves of a Seasoned Value Investor Robert Bruce (Trades, Portfolio) recently submitted the 13F filing for the fourth quarter of 2025, p
KOD Stock Up 24% in 3 Months: Here's What You Need to Know
12:35pm, Friday, 06'th Feb 2026
Kodiak Sciences' shares jump 24% in three months as late-stage retinal programs advance and fresh funding extends its cash runway, fueling investor confidence.
Final APEX Phase 1b Clinical Results for Kodiak's KSI-101 in Macular Edema Secondary to Inflammation to be Presented at Angiogenesis 2026
07:00am, Wednesday, 04'th Feb 2026
PALO ALTO, Calif., Feb. 4, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing trans
Kodiak Sciences Inc. (NASDAQ:KOD) Receives $26.57 Average PT from Brokerages
03:52am, Wednesday, 14'th Jan 2026
Shares of Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) have been given a consensus rating of "Moderate Buy" by the eight research firms that are currently covering the firm, MarketBeat.com rep
Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
08:45pm, Monday, 12'th Jan 2026
Kodiak Sciences Inc. (KOD) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Kodiak Sciences to Present at 44th Annual J.P. Morgan Healthcare Conference
08:19pm, Wednesday, 07'th Jan 2026
PALO ALTO, Calif., Jan. 7, 2026 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing trans
Kodiak Sciences (NASDAQ:KOD) Shares Down 5.8% – What’s Next?
02:36am, Sunday, 28'th Dec 2025
Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shares traded down 5.8% during mid-day trading on Friday. The stock traded as low as $29.27 and last traded at $29.2750. 145,497 shares changed han
Kodiak Sciences (NASDAQ:KOD) Hits New 12-Month High – Here’s What Happened
04:37am, Thursday, 25'th Dec 2025
Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report)'s stock price hit a new 52-week high during trading on Tuesday. The company traded as high as $29.49 and last traded at $28.61, with a volume of 12
Kodiak Sciences (NASDAQ:KOD) Shares Gap Up Following Insider Buying Activity
01:16am, Tuesday, 23'rd Dec 2025
Kodiak Sciences Inc. (NASDAQ: KOD - Get Free Report) shares gapped up prior to trading on Monday after an insider bought additional shares in the company. The stock had previously closed at $26.00, bu
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025
11:16am, Monday, 22'nd Dec 2025
IONS, GPCR, MNPR and KOD more than double in 2025 as policy clarity, M&A revival and clinical wins lift biotech momentum into 2026.
First Look: Gold hits records, Jim Beam pause, Apple fined
07:37am, Monday, 22'nd Dec 2025
Stock News Gold and silver set new records: Spot gold and silver surged to fresh allâtime highs on haven demand and rateâcut bets, with iShares MSCI Global
